US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 9.920
  • +1.980+24.94%
Close Aug 9 16:00 ET
  • 9.860
  • -0.060-0.60%
Post 20:01 ET
3.01BMarket Cap-5940P/E (TTM)

Iovance Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Iovance Biotherapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 8, 2024

Revenue(YoY)

31.11M

+12969.75%
EPS(YoY)

-0.34

+27.66%
Analyst Rating

Strong Buy

Aug 10, 2024

Iovance Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 77.000M--
--2024/Q3-- / 53.692M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--
Feb 28, 20242023/Q4482.000K / 1.399M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 77.000M--
--2024/Q3-- / 53.692M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--
Feb 28, 20242023/Q4482.000K / 1.399M--

Unlock Free Earnings Estimates

Iovance Biotherapeutics Earnings Reports

  • Iovance Biotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 17:15 ET

  • Iovance Biotherapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 17:16 ET

  • Iovance Biotherapeutics | 10-K: FY2023 Annual Report

    Feb 28 22:33 ET

  • Iovance Biotherapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 17:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 10, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-4.29%